top of page
THE
ARCHIVES
Rapamycin in Longevity Medicine: Precision mTOR Inhibition for Healthspan Extension
Rapamycin is the only pharmacological agent proven to reproducibly extend mammalian lifespan across independent labs. This evidence-based executive brief synthesizes 8 peer-reviewed studies — including the 2025 PEARL trial, the first placebo-controlled human healthspan trial — covering mechanism, dosing, monitoring, and safety for precision aging medicine.
12 min read
bottom of page